Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.1M | $60.4M | $83.9M | $107M | $112M | $127M | $139M | $159M | $187M | $225M |
| Revenue growth | — | 47.0% | 38.9% | 27.1% | 5.2% | 13.4% | 8.8% | 14.7% | 17.8% | 20.2% |
| Gross profit | $34.6M | $51.1M | $71.0M | $89.4M | $90.7M | $104M | $109M | $122M | $142M | $167M |
| Gross margin | 84.3% | 84.6% | 84.6% | 83.7% | 80.8% | 82.0% | 78.5% | 76.6% | 75.8% | 74.3% |
| Operating income | -$8.13M | -$7.95M | -$20.5M | -$31.4M | -$23.2M | -$25.4M | -$29.7M | -$21.5M | -$3.29M | -$7.85M |
| Operating margin | -19.8% | -13.2% | -24.4% | -29.4% | -20.6% | -20.0% | -21.4% | -13.5% | -1.8% | -3.5% |
| Net income | -$14.4M | -$10.4M | -$22.4M | -$29.1M | -$23.8M | -$27.0M | -$28.9M | -$21.7M | -$9.96M | -$15.7M |
| Net margin | -35.1% | -17.3% | -26.7% | -27.3% | -21.2% | -21.2% | -20.9% | -13.7% | -5.3% | -7.0% |
| EPS (diluted) | -$0.47 | -$0.31 | -$0.60 | -$0.74 | -$0.60 | -$0.65 | -$0.69 | -$0.51 | -$0.23 | -$0.34 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$11.2M | -$9.24M | -$17.9M | -$19.9M | -$9.63M | -$13.4M | -$16.1M | -$5.72M | $4.54M | $812K |
| Capital expenditures | $931K | $1.10M | $6.28M | $4.66M | $21.9M | $27.8M | $20.1M | $13.9M | $3.10M | $3.75M |
| Free cash flow | -$12.2M | -$10.3M | -$24.1M | -$24.5M | -$31.5M | -$41.2M | -$36.1M | -$19.6M | $1.43M | -$2.93M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $30.0M | $36.5M | $24.3M | $35.7M | $48.8M | $32.8M | $15.3M | $31.0M | $27.6M | $35.5M |
| Total assets | $46.4M | $58.9M | $160M | $155M | $201M | $208M | $195M | $197M | $204M | $222M |
| Total liabilities | $31.4M | $33.7M | $13.2M | $22.5M | $78.2M | $95.5M | $94.4M | $101M | $99.8M | $92.8M |
| Long-term debt | $20.3M | $19.8M | $35.0K | $0.00 | $32.0M | $44.8M | $45.7M | $46.6M | $47.5M | $48.4M |
| Shareholders' equity | $14.9M | $25.2M | $147M | $132M | $123M | $113M | $101M | $95.7M | $104M | $129M |
| Retained earnings | -$118M | -$128M | -$151M | -$180M | -$204M | -$231M | -$260M | -$281M | -$291M | -$307M |
| Shares (wtd avg diluted) | 33.0M | 34.4M | 38.9M | 39.2M | 40.0M | 41.2M | 42.1M | 42.9M | 44.3M | 46.1M |
Every figure is extracted from Axogen, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.